Composition and preparation method thereof as well as oral liquid and preparation method of oral liquid

A composition and solution technology, applied in the direction of drug combination, active ingredient of heterocyclic compound, pharmaceutical formula, etc.

Active Publication Date: 2015-06-03
BEIJING HANMI PHARMA CO LTD
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

So far, there is still no effective solution to the incompatibility between montelukast sodium and levocetirizine hydrochloride

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition and preparation method thereof as well as oral liquid and preparation method of oral liquid
  • Composition and preparation method thereof as well as oral liquid and preparation method of oral liquid
  • Composition and preparation method thereof as well as oral liquid and preparation method of oral liquid

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] The preparation of embodiment 1 oral liquid

[0044] The prescription of oral liquid is shown in Table 1. All operations were performed under dark conditions.

[0045] Table 1 Prescription of Oral Solution

[0046] prescription composition prescription dosage Montelukast sodium (mg) 104 Levocetirizine hydrochloride (mg) 100 Meglumine (mg) 10 Hydroxypropyl-β-cyclodextrin (mg) 15000 Acesulfame K (mg) 50 Grape essence (mg) 60 Cetylpyridinium chloride (mg) 100 water (mL) 100 pH 7.38

[0047] Dissolve cetylpyridinium chloride in water, add meglumine and acesulfame potassium and stir to dissolve, add hydroxypropyl-β-cyclodextrin and stir to dissolve, add grape essence and stir to dissolve, add montelukast sodium and stir to dissolve, and obtain montelukast sodium Lukast sodium solution.

[0048] Dissolve levocetirizine hydrochloride in water, and adjust the pH to 7 with 1% sodium hydroxide to obtain levoc...

Embodiment 2

[0049] Embodiment 2 preparation of oral liquid

[0050] The prescription of oral liquid is as shown in table 2. All operations were performed under dark conditions.

[0051] Table 2 Prescription of Oral Solution

[0052]

[0053]

[0054] Dissolve cetylpyridinium chloride in water, add potassium sorbate and acesulfame potassium and stir to dissolve, add hydroxypropyl-β-cyclodextrin and stir to dissolve, add grape essence and stir to dissolve, add montelukast sodium and stir to dissolve, and obtain montelukast sodium Lukast sodium solution.

[0055] Dissolve levocetirizine hydrochloride in water and adjust the pH to 6.5 with 1% sodium hydroxide to obtain levocetirizine hydrochloride solution. Add levocetirizine hydrochloride solution to the above-mentioned montelukast sodium solution, and stir while adding to obtain the product.

Embodiment 3

[0056] Embodiment 3 preparation of oral liquid

[0057] The prescription of oral liquid is as shown in table 3. All operations were performed under dark conditions.

[0058] Table 3 Prescription of Oral Solution

[0059] prescription composition prescription dosage Montelukast sodium (mg) 50 Levocetirizine hydrochloride (mg) 500 Meglumine (mg) 40 Hydroxypropyl-β-cyclodextrin (mg) 20000 Acesulfame K (mg) 10 Grape essence (mg) 200 Cetylpyridinium chloride (mg) 200 water (mL) 100 pH 7.92

[0060] [0060] Dissolve cetylpyridinium chloride in water, add meglumine and acesulfame potassium and stir to dissolve, add hydroxypropyl-β-cyclodextrin and stir to dissolve, add grape essence and stir to dissolve, add montelukast sodium and stir to dissolve, and obtain montelukast sodium Lukast sodium solution.

[0061] Dissolve levocetirizine hydrochloride in water, and adjust the pH to 8 with 1% sodium hydroxide to obta...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicinal preparations, in particular to a composition and a preparation method thereof as well as an oral liquid and a preparation method of the oral liquid. The preparation method of the composition comprises the following steps: mixing montelukast sodium with first water to obtain a montelukast sodium solution; mixing levocetirizine hydrochloride with second water and adjusting the pH value to 6.5-9 to obtain a levocetirizine hydrochloride solution; mixing the montelukast sodium solution with the levocetirizine hydrochloride solution to obtain the composition. The montelukast sodium in the oral liquid provided by the invention is high in stability; the composition does not contain an organic solvent or a surfactant; medication of children is facilitated; and the preparation technology is simple.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a composition and a preparation method thereof, an oral liquid and a preparation method thereof. Background technique [0002] Allergic rhinitis (allergic rhinitis, AR) is a multifactorial disease induced by the interaction of genes and the environment. It is a mediator mainly mediated by IgE after exposure to allergens in atopic individuals. (mainly histamine) release, and a variety of immune active cells and cytokines involved in the nasal mucosa non-infectious inflammatory disease. There are three necessary conditions for its occurrence: ① specific antigen is the substance that causes the body's immune response; ② atopic individual is the so-called individual difference and allergic constitution; ③ specific antigen meets the atopic individual. Specific antigens are derived from animals, plants, insects, fungi or occupational substances, such as mites, pollen, animal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/495A61K9/00A61K47/02A61P11/02A61P37/08A61K31/47
Inventor 闫学文方翼杨慧君成仁基
Owner BEIJING HANMI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap